Investment objective

To provide long-term capital growth by investing primarily in equity securities of companies outside of North America. The fund provides exposure to economies that offer different business cycles and growth opportunities than North American markets.

Download fund details    Download fund commentary   

Fund details

Series
Currency
Fund code
MER * (%)
F CAD 35072 0.99%

Portfolio analysis As of May 31, 2025

96% 4%
Equity Fixed Income

Asset mix

Equity Sector Allocation
Financials24.7%
Industrials19.3%
Health Care12.6%
Information Technology11.4%
Consumer Discretionary11.0%
Consumer Staples6.5%
Materials5.1%
Communication Services3.5%
Energy2.7%
Utilities2.7%
Real Estate0.5%
Top 10 Holdings
% Assets
Hitachi Ltd 2.8%
Mitsubishi Heavy Industries Ltd 2.8%
Novo Nordisk A/S - Class B Shares 2.7%
Sony Group Corp 2.6%
EssilorLuxottica SA 2.4%
Allianz SE 2.4%
ASML Holding NV 2.3%
Roche Holding AG 2.2%
Taiwan Semiconductor Manufacturing Co Ltd 2.0%
AstraZeneca PLC 1.9%
Total % of Top 10 Holdings 24.1%

Geographic allocation

Region

Performance analysis

Growth of $10,000 since inception

Calendar returns

Trailing return

1 Mth 3 Mth 6 Mth 1 year 3 years 5 years 10 years Since Inception
4.3 0.6 5.5 6.9 12.1 9.1 6.9 4.8 Fund

Distribution ($)/unit

YTD* 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Total distributions 0.00 0.37 0.43 1.11 0.18 0.20 0.36 0.42 0.21 0.22 0.16
Interest --- 0.01 0.01 0.01 0.00 0.01 0.00 0.00 --- --- ---
Canadian dividends --- --- --- --- --- --- --- --- --- --- ---
Foreign dividends --- 0.42 0.48 1.18 0.20 0.21 0.39 0.48 0.24 0.25 0.19
Foreign taxes paid --- -0.05 -0.06 -0.07 -0.02 -0.02 -0.04 -0.06 -0.03 -0.03 -0.03
Capital gains --- --- --- --- --- --- --- --- --- --- ---
Return of capital --- --- --- --- --- --- --- --- --- --- ---

* MER (%) is based on actual expenses for the preceding calendar year or most recent half-year period ended June 30 expressed on an annualized basis, depending on availability of date at the time of publication.